Windfall Bio raises $28 million in Series A funding led by Prelude Ventures, with participation from Amazon’s Climate Pledge Fund, Global Brain, Incite Ventures, and Positive Ventures to scale methane capture and transformation solution.
Amount Raised
$28 Million
Round Type
Series A
Menlo ParkBiotechnologyAgriculture and FarmingInvestors
Description
Windfall Bio, a leader in methane-to-value solutions, announced its $28 million Series A funding round led by Prelude Ventures with participation from Amazon’s Climate Pledge Fund, Global Brain (through its Norinchukin Innovation Fund L.P.), Incite Ventures, and Positive Ventures. Existing investors also participated in the round, including B37 Ventures, Breakthrough Energy Ventures, Mayfield, and UNTITLED (a fund backed by the Tetra Laval family). Supporting its commercial pipeline, the new capital will enable Windfall to expand pilot deployments across methane intensive industries including agriculture, oil and gas, and waste management. Windfall will also invest resources to continue building out its team, manufacturing capacity and supply chain to meet growing global customer demand for methane mitigation solutions.
Quick answer
Windfall Bio raised $28 Million in a Series A round, dated April 8, 2024. Investors: Untitled (A Fund Backed By The Tetra Laval Family), Mayfield, Breakthrough Energy Ventures, B37 Ventures, Positive Ventures, Incite Ventures, Global Brain and Amazon’s Climate Pledge Fund. Windfall Bio is based in Menlo Park, California, United States.
- How much did Windfall Bio raise?
- Windfall Bio raised $28 Million in a Series A round on April 8, 2024.
- Who invested in Windfall Bio?
- Untitled (A Fund Backed By The Tetra Laval Family), Mayfield, Breakthrough Energy Ventures, B37 Ventures, Positive Ventures, Incite Ventures, Global Brain and Amazon’s Climate Pledge Fund are named as investors in this round.
- What does Windfall Bio do?
- Windfall Bio is a nature-based agricultural technology company that harnesses methane-eating microbes to transform harmful methane into organic soil nutrients on site.
- Where is Windfall Bio based and how big is it?
- Windfall Bio is based in Menlo Park, California, United States.
- Who are the decision-makers at Windfall Bio?
- Fundz holds 1 contact at Windfall Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Agriculture and Farming and Biotechnology around the same time
Companies in the same sectors as Windfall Bio that raised within 45 days of this round, from Fundz verified event records.
- 22nd Century raised $4.2M (Seed) on April 8, 2024.
- Cauldron raised $6.3M (Series A) on March 20, 2024.
- Cauldron raised $9.5M (Series A) on March 18, 2024.
- Bicycle Therapeutics raised $555M (Post-IPO Equity) on May 23, 2024.
- Turn Therapeutics Inc. raised an undisclosed amount on May 23, 2024.
- Grey Wolf Therapeutics raised $50M (Series B) on May 23, 2024.
Who to call at Windfall Bio, and when
A new round usually means Windfall Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Windfall Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Windfall Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Windfall Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Windfall Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansWindfall Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.